The legal complaint, filed by the DJS Law Group, asserts that PROCEPT violated the Securities Exchange Act of 1934 by pulling sales forward from future periods. This strategy allegedly created an artificial surplus of inventory in the market, rendering the company's public financial statements materially misleading. Shareholders seeking to participate in the recovery process or apply for lead plaintiff status are encouraged to reach out to the firm before the late September cutoff.

While the lawsuit targets specific accounting and disclosure practices, the litigation represents a significant test for the company’s market credibility. PROCEPT BioRobotics, traded under the ticker PRCT, has yet to address the specific allegations regarding its revenue recognition policies. Legal representatives emphasize that individual investors do not need to be appointed as lead plaintiffs to recover potential losses from the class action settlement, should the court rule in favor of the claimants.